A61K 9/4816
Wall or shell material
Official title: {Wall or shell material}
A61K9/4816 (Wall or shell material) appears on 1,390 US grants and 2,502 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,390
- Published applications
- 2,502
- Assignees
- 996
- Inventors
- 3,977
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 0 | 0 |
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 3 | 0 |
| 1983 | 4 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 3 | 0 |
| 1987 | 7 | 0 |
| 1988 | 8 | 0 |
| 1989 | 4 | 0 |
| 1990 | 4 | 0 |
| 1991 | 5 | 0 |
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 6 | 0 |
| 1995 | 7 | 0 |
| 1996 | 2 | 0 |
| 1997 | 12 | 0 |
| 1998 | 7 | 0 |
| 1999 | 9 | 0 |
| 2000 | 3 | 0 |
| 2001 | 17 | 7 |
| 2002 | 9 | 22 |
| 2003 | 15 | 34 |
| 2004 | 10 | 42 |
| 2005 | 11 | 42 |
| 2006 | 11 | 33 |
| 2007 | 12 | 39 |
| 2008 | 6 | 43 |
| 2009 | 6 | 31 |
| 2010 | 19 | 59 |
| 2011 | 19 | 58 |
| 2012 | 35 | 72 |
| 2013 | 40 | 74 |
| 2014 | 66 | 131 |
| 2015 | 83 | 128 |
| 2016 | 58 | 137 |
| 2017 | 85 | 163 |
| 2018 | 73 | 132 |
| 2019 | 100 | 153 |
| 2020 | 100 | 162 |
| 2021 | 100 | 170 |
| 2022 | 103 | 159 |
| 2023 | 69 | 161 |
| 2024 | 89 | 210 |
| 2025 | 81 | 140 |
| 2026 | 74 | 100 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Polysaccharide encapsulated oxygen nanobubbles6 Oct 2026US 12,751,927 B2The Board of Trustees of the University of Illinois
- Pharmaceutical compounds and methods of making and using the same29 Sep 2026US 12,747,208 B2Athos Therapeutics, Inc.
- Cabozantinib compositions and methods of use22 Sep 2026US 12,741,938 B2Handa Oncology, LLC
- Dopamine receptor d1 agonists and methods of use22 Sep 2026US 12,741,940 B2Mayo Foundation for Medical Education and Research
- Cytokine immunotherapy22 Sep 2026US 12,742,182 B2VLP Therapeutics, LLC
- Production of a pharmaceutical dosage form from horseradish and nasturtium8 Oct 2026US 2026/0306570 A1Kwizda Pharma GmbH
- Cannabidiol formulations1 Oct 2026US 2026/0294812 A1Dsm IP Assets B.V.
- Cosmetic composition for preventing, alleviating or ameliorating alopecia1 Oct 2026US 2026/0294852 A1LG Chem.Ltd.
- Autophagy activator and autophagy activation composition1 Oct 2026US 2026/0294865 A1Maruzen Pharmaceuticals Co., Ltd.
- Methods for the treatment of childhood-onset fluency disorder1 Oct 2026US 2026/0294924 A1Noema Pharma AG
Most cited
By later US patents
- Implantable biocompatable immunoisolatory vehicle for delivery of selected therapeutic products448US 6,083,523 ABrown University · 2000
- Inhibitors of bruton's tyrosine kinase306US 7,514,444 B2Pharmacyclics, Inc. · 2009
- Chewable, edible soft gelatin capsule305US 4,935,243 APharmacaps, Inc. · 1990
- Compositions and methods239US 9,011,834 B1Seres Health, Inc. · 2015
- Polymer composition for injection molding202US 4,673,438 AWarner-Lambert Company · 1987